Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674084 | SCV000799358 | likely pathogenic | Hurler syndrome | 2018-04-16 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001784291 | SCV002016667 | likely pathogenic | not provided | 2022-01-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001861834 | SCV002312979 | pathogenic | Mucopolysaccharidosis type 1 | 2023-07-14 | criteria provided, single submitter | clinical testing | This variant, c.1045_1047del, results in the deletion of 1 amino acid(s) of the IDUA protein (p.Asp349del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.06%). This variant has been observed in individuals with mucopolysaccharidosis type I (PMID: 21394825, 27392569). ClinVar contains an entry for this variant (Variation ID: 557885). This variant disrupts a region of the IDUA protein in which other variant(s) (p.Asp349Tyr) have been determined to be pathogenic (PMID: 12203999, 12559846, 28752568, 30809705). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Center for Genomic Medicine, |
RCV000674084 | SCV004810094 | likely pathogenic | Hurler syndrome | 2024-04-04 | criteria provided, single submitter | clinical testing |